OLBA HEALTHCARE HOLDINGS, Inc. (2689) AI Stock Analysis

• Market Cap: ¥12.56B
• Dividend Yield: 3.9%
• Average Volume (3M): 2.71K
• Price to Earnings (P/E): 8.6
• Beta (1Y): 0.30
• Revenue Growth: 3.64%
• EPS Growth: -4.70%
• Country: JP
• Employees: 1,354
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Distribution
• EPS (TTM): 28.14
• Shares Outstanding: 6,250,000
• 10 Day Avg. Volume: 2,760
• 30 Day Avg. Volume: 2,706
• PEG Ratio: -2.04
• Price to Book (P/B): 0.97
• Price to Sales (P/S): 0.10
• P/FCF Ratio: 65.46
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 71 Outperform
• Price Target: ¥2,240.00 ▲(9.54% Upside)

OLBA HEALTHCARE HOLDINGS, Inc. receives a strong score driven by solid financial performance and attractive valuation. The company's stable operational performance and undervalued P/E ratio are significant strengths. Technical indicators suggest mild bullish momentum, supporting a positive outlook. However, attention to debt levels and cash flow alignment remains important.

Positive Factors

Revenue Growth

Consistent revenue growth indicates expanding market presence and successful product adoption, supporting long-term business sustainability.

Strong Balance Sheet

A strong balance sheet with improved debt management enhances financial stability, providing resilience against economic fluctuations.

Operational Performance

Efficient cost management leading to healthy gross profit margins supports sustained profitability and competitive advantage.

Negative Factors

Cash Flow Volatility

Volatile cash flow can challenge financial planning and investment capacity, necessitating improved cash flow management for stability.

Net Profit Margin Pressure

Decreasing net profit margins can impact overall profitability, requiring strategic adjustments to maintain financial health.

Debt Levels

Rising debt levels may strain financial resources, necessitating prudent management to avoid long-term financial constraints.

OLBA HEALTHCARE HOLDINGS, Inc. Business Overview & Revenue Model

Company Description

OLBA HEALTHCARE HOLDINGS, Inc. provides various solutions to medical institutions, universities, corporate research institutes, individuals, and long-term care facilities in Japan. The company's medical equipment business engages in the wholesale of artificial joints, pacemakers, coronary stents, steel instruments, and ultrasonic scalpels; and diagnostic imaging equipment, such as MRI and CT to respirators, intraoperative monitors, and surgical lights. It also offers reagents and equipment for genetic research, cell culture, and protein analysis; automatic analyzers for biochemistry, immunity, and blood; and test reagents, as well as undertakes services for DNA analysis in the field of life sciences. The company's Supply Processing and Distribution business provides goods management, information management, and purchase management services. Its Nursing care products business engages in the rental of nursing care equipment; sale of welfare equipment, such as portable toilets and bathing equipment; and operation of long-term care reform, a comfortable stay at home. The company was formerly known as Kawanishi Holdings, Inc. and changed its name to OLBA HEALTHCARE HOLDINGS, Inc. in January 2021. OLBA HEALTHCARE HOLDINGS, Inc. was founded in 1921 and is headquartered in Okayama, Japan.

How the Company Makes Money

OLBA HEALTHCARE HOLDINGS, Inc. generates revenue through multiple streams, primarily from the sale of medical devices and pharmaceuticals. The company licenses its products to hospitals and healthcare providers, which forms a significant portion of its revenue. Additionally, OLBA engages in research and development partnerships with other healthcare organizations and universities, allowing it to monetize innovative healthcare solutions and technologies. The company also benefits from government contracts and grants that support its healthcare initiatives, further contributing to its earnings. By maintaining strong relationships with key industry players, OLBA is able to tap into emerging market opportunities, enhancing its revenue potential.

OLBA HEALTHCARE HOLDINGS, Inc. Financial Statement Overview

Summary

OLBA HEALTHCARE HOLDINGS, Inc. shows strong revenue growth and stable operational performance. The balance sheet is solid with a healthy equity base and improving debt management. Cash flow metrics indicate some volatility, but recent trends are encouraging. Overall, the company is in a good financial position, though careful attention to debt levels and cash flow alignment is advisable.

Income Statement

OLBA HEALTHCARE HOLDINGS, Inc. has demonstrated strong revenue growth with a 0.87% increase in the latest year. The gross profit margin is healthy, reflecting efficient cost management. However, the net profit margin has slightly decreased, indicating some pressure on profitability. The EBIT and EBITDA margins are stable, suggesting consistent operational performance.

Balance Sheet

The company maintains a solid equity base with a debt-to-equity ratio that has improved over time, indicating prudent financial management. Return on equity is strong, reflecting effective use of shareholder funds. The equity ratio is robust, showcasing a stable financial position. However, the increase in total debt over the years could pose a potential risk if not managed carefully.

Cash Flow

Operating cash flow has shown volatility, but recent improvements are promising. The free cash flow growth is positive, although the free cash flow to net income ratio indicates room for improvement in cash generation relative to earnings. The operating cash flow to net income ratio suggests a need for better alignment between cash flows and reported earnings.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	122.70B	122.70B	118.56B	110.47B	107.96B	112.98B
Gross Profit	13.91B	13.91B	13.60B	12.95B	12.50B	11.60B
EBITDA	2.59B	2.59B	2.83B	2.68B	2.56B	1.94B
Net Income	1.43B	1.43B	1.50B	1.41B	1.54B	989.37M
Balance Sheet
Total Assets	45.87B	45.87B	43.24B	40.88B	39.97B	36.56B
Cash, Cash Equivalents and Short-Term Investments	3.47B	3.47B	2.73B	2.40B	3.19B	2.16B
Total Debt	2.95B	2.95B	1.63B	1.92B	1.28B	1.96B
Total Liabilities	33.56B	33.56B	31.86B	30.55B	30.88B	28.43B
Stockholders Equity	12.26B	12.26B	11.37B	10.33B	9.09B	8.13B
Cash Flow
Free Cash Flow	0.00	181.25M	1.61B	-910.52M	1.97B	2.49B
Operating Cash Flow	0.00	1.63B	2.08B	-659.52M	2.42B	3.13B
Investing Cash Flow	0.00	-1.64B	-673.03M	-306.25M	-211.81M	-630.38M
Financing Cash Flow	0.00	686.95M	-1.09B	175.94M	-1.17B	-2.26B

OLBA HEALTHCARE HOLDINGS, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 2045.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2689, the sentiment is Positive. The current price of 2045 is below the 20-day moving average (MA) of 2049.00, above the 50-day MA of 2032.16, and above the 200-day MA of 2033.62, indicating a bullish trend. The MACD of 11.12 indicates Negative momentum. The RSI at 57.57 is Neutral, neither overbought nor oversold. The STOCH value of 62.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2689.

OLBA HEALTHCARE HOLDINGS, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3183	74 Outperform	¥38.38B	17.38	―	3.97%	6.63%	11.04%
3417	73 Outperform	¥19.57B	6.84	―	1.83%	4.30%	52.38%
2689	71 Outperform	¥12.56B	8.56	―	3.90%	3.64%	-4.70%
9265	70 Outperform	¥8.42B	15.32	―	1.87%	2.65%	8.83%
4350	70 Outperform	¥15.33B	9.85	―	2.32%	6.60%	27.97%
3151	67 Neutral	¥65.02B	7.08	―	4.22%	2.23%	72.07%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

OLBA HEALTHCARE HOLDINGS, Inc. Corporate Events

OLBA HEALTHCARE HOLDINGS Reports Q3 2025 Financial Results

OLBA HEALTHCARE HOLDINGS, Inc. reported a 6.1% increase in net sales for the three months ending September 30, 2025, compared to the previous year. Despite the rise in sales, the company experienced a decline in operating and ordinary profits by 7.3% and 10.0%, respectively, indicating potential challenges in managing operational costs or market conditions. The company’s equity ratio also saw a slight decrease, reflecting changes in its financial structure. The forecast for the fiscal year ending June 30, 2026, anticipates modest growth in net sales and operating profit, suggesting cautious optimism in the company’s future performance.

The most recent analyst rating on (JP:2689) stock is a Buy with a Yen2240.00 price target. To see the full list of analyst forecasts on OLBA HEALTHCARE HOLDINGS, Inc. stock, see the JP:2689 Stock Forecast page.